KK
Kristen Kluska Cantor Fitzgerald Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
47
Avg Return
Past Year
Past Year
35%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
87.5%
Neutral
12.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Initiated
| $19 |
110%
upside
| 2 | +0.13% |
0
%
| 1 Dec ‘25 4 days ago |
|
|
|
Overweight
Maintained
| $24 |
177%
upside
| 1 | +4.4% |
0
%
| 6 Nov ‘25 29 days ago |
|
|
|
Neutral
Maintained
| $38 |
19%
downside
| 1 | – |
–
| 5 Nov ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $153 |
63%
upside
| 1 | +36% |
0
%
| 17 Oct ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $63 |
40%
upside
| 1 | +11% |
0
%
| 30 Sep ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $80 |
246%
upside
| 1 | +250% |
0
%
| 25 Sep ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| $105 |
187%
upside
| 1 | -1.3% |
0
%
| 5 Sep ‘25 3 months ago |
|